摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,2'-Dithiobis- | 82993-28-0

中文名称
——
中文别名
——
英文名称
2,2'-Dithiobis-
英文别名
2,2'-disulfanediyl-bis-thiazole-4-carboxylic acid diethyl ester;Ethyl 2-[(4-ethoxycarbonyl-1,3-thiazol-2-yl)disulfanyl]-1,3-thiazole-4-carboxylate
2,2'-Dithiobis-<thiazol-carbonsaeure-(4)-aethylester>化学式
CAS
82993-28-0
化学式
C12H12N2O4S4
mdl
——
分子量
376.502
InChiKey
SETPNXUFTMNOCB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    22
  • 可旋转键数:
    9
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    186
  • 氢给体数:
    0
  • 氢受体数:
    10

反应信息

  • 作为产物:
    描述:
    2-巯基噻唑-4-羧酸乙酯 在 ammonium peroxydisulfate 作用下, 生成 2,2'-Dithiobis-
    参考文献:
    名称:
    Thiazolethiols and Their Derivatives
    摘要:
    DOI:
    10.1021/jo01078a014
点击查看最新优质反应信息

文献信息

  • METHOD OF IMMUNOMODULATION USING THIONE-FORMING DISULFIDES
    申请人:The GRASSETTI Family Trust
    公开号:EP1383499B1
    公开(公告)日:2013-03-06
  • COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
    申请人:Novartis AG
    公开号:EP3880673A1
    公开(公告)日:2021-09-22
  • Method of immunomodulation using thione-forming disulfides
    申请人:——
    公开号:US20040265327A1
    公开(公告)日:2004-12-30
    The invention provides for the methods of modulating an immune response in an individual by administration of a thione-forming disulfide (TFD). Immunomodulatory responses include, but are not limited to, increased natural killer cell activity, expansion of NK cell population, decreased B cell population, decreased antibody production, and increased mitogenic potential. Methods of modulating such immune responses and the uses of immunomodulation are provided herein.
  • Inhibition of IL-1 Induced Inflammation
    申请人:THIOLAB, LLC.
    公开号:US20220193060A1
    公开(公告)日:2022-06-23
    This invention provides methods of treatment for a variety of inflammation pathologies using thione-forming disulfides (TFDs). The treatments are particularly effective in the context of inflammations primarily due to excessive activity of innate immune system components, macrophage activity and inflammation arising from excessive production of IL-1. TFD inhibition of both IL-1 and IL-6 can reduce the detrimental effects of the cytokine storms known to increase morbidity and mortality caused by certain infections, such as COVID-19 viral pneumonia.
  • US4378364A
    申请人:——
    公开号:US4378364A
    公开(公告)日:1983-03-29
查看更多